NCT05060302

Brief Summary

In postoperative thoracic surgery (lobe resection, pneumonectomy or wedge resection), cardiovascular complications are the most frequent (10 to 15%) with a significant morbi-mortality rate. Right ventricular (RV) dysfunction is a complication that can be multifactorial in post thoracic surgery. The RV longitudinal shortening fraction (RV-LSF) is a new 2D-STE parameters able to more accurately detect patients with RV dysfunction compared to conventional echocardiographic parameters. This project is a single-center, prospective, interventional study of patients hospitalized at the Amiens University Hospital for scheduled thoracic surgery. TTE is performed preoperatively, at day 2 and day 15 following the thoracic surgery. Echocardiographic parameters will be measured by an echocardiographic expert in offline with a dedicated software. MACE criteria will be collected at day 2, day 15 and day-30 following the thoracic surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

September 15, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 29, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

3 years

First QC Date

September 15, 2021

Last Update Submit

February 7, 2023

Conditions

Keywords

Right ventriclespeckle trackingthoracic surgery

Outcome Measures

Primary Outcomes (1)

  • occurrence of a major cardiovascular event (MACE)

    MACE is a composite criteria. MACES criteria is defined as the occurrence of at least one of the following events: A cardiovascular death or a documented supraventricular tachycardia (atrial fibrillation and/or flutter) of duration \> 30 seconds or, an acute myocardial infarction or, an hospitalization for a right ventricular failure or, an hospitalization for a left ventricular failure.

    day 30

Secondary Outcomes (10)

  • Variation of RV systolic function from baseline in patients with MACE

    at day 1

  • Variation of RV systolic function from baseline in patients without MACE

    at day 1

  • Variation of RV systolic function from baseline in patients with MACE

    at day 2

  • Variation of RV systolic function from baseline in patients without MACE

    at day 2

  • Variation of RV systolic function from baseline in patients with MACE

    at day 15

  • +5 more secondary outcomes

Interventions

the included patients have a TTE preoperatively in order to evaluate the RV systolic function. TTE will also be done at day 2 and day-15 during the follow-up surgical consultation.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient (\>18 years)
  • Patient hospitalized at the Amiens University Hospital for scheduled thoracic surgery (lobectomy, pneumonectomy, wedge resection).
  • Surgery by thoracotomy or video-assisted thoracic surgery
  • Information of the patient and collection of his non-opposition

You may not qualify if:

  • Patient with poor echogenicity on TTE not allowing evaluation of 2D-STE or conventional parameters of the RV.
  • Patient with a rapid supraventricular rhythm disorder (HR \> 100) at the time of TTE
  • Patient under mechanical ventilation
  • Patient under extracorporeal membrane oxygenation
  • Patients under guardianship or legal protection
  • Patients whose clinical condition does not allow for their non-opposition
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens Picardie

Amiens, France

RECRUITING

Central Study Contacts

Christophe Beyls, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2021

First Posted

September 29, 2021

Study Start

September 15, 2021

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations